Showing results (11-20 of 58) with videos related to

Sort By:
Pageof 6
Journal of the American College of Cardiology|January 5, 2002
Improved post-myocardial infarction survival with probucol in rats: effects on left ventricular function, morphology, cardiac oxidative stress and cytokine expressionYing Tung Sia, Thomas G Parker, Peter Liu, et al.
Journal of Cardiovascular Pharmacology|December 18, 2001
Long-term effects of carvedilol on left ventricular function, remodeling, and expression of cardiac cytokines after large myocardial infarction in the ratYing Tung Sia, Thomas G Parker, James N Tsoporis, et al.
Life Sciences|September 25, 2012
S100B: role in cardiac remodeling and function following myocardial infarction in diabetesForough Mohammadzadeh, Jean-Francois Desjardins, James N Tsoporis, et al.
Experimental and Therapeutic Medicine|April 3, 2026
Disrupted beginnings: Neurodevelopmental outcomes of COVID-19 lockdowns in early childhood (Review)Ioanna Giannopoulou, Vasiliki Efstathiou, Maria-Ioanna Stefanou, et al.
Shock (Augusta, Ga.)|December 22, 2020
Toll-Like Receptors, Associated Biochemical Signaling Networks, and S100 LigandsSahil Gupta, James N Tsoporis, Song-Hui Jia, et al.
Cardiovascular Research|November 15, 2014
Absence of the calcium-binding protein, S100A1, confers pulmonary hypertension in mice associated with endothelial dysfunction and apoptosisKrystyna Teichert-Kuliszewska, James N Tsoporis, Jean-Francois Desjardins, et al.
American Journal of Physiology. Heart and Circulatory Physiology|November 13, 2004
Effects of pre-, peri-, and postmyocardial infarction treatment with losartan in rats: effect of dose on survival, ventricular arrhythmias, function, and remodelingAli Pourdjabbar, Thomas G Parker, Quang Trinh Nguyen, et al.
Canadian Journal of Physiology and Pharmacology|January 5, 2006
Losartan and acute myocardial infarction in insulin-resistant Zucker fatty rats: reduced ventricular arrhythmias and improved survivalAli Pourdjabbar, Thomas G Parker, Jean-François Desjardins, et al.
Stem Cell Reviews and Reports|November 30, 2013
Donor mesenchymal stromal cells (MSCs) undergo variable cardiac reprogramming in vivo and predominantly co-express cardiac and stromal determinants after experimental acute myocardial infarctionGustavo Yannarelli, James N Tsoporis, Jean-Francois Desjardins, et al.
Stem Cell Reviews and Reports|July 17, 2020
Genetically Modified Mesenchymal Stromal/Stem Cells: Application in Critical IllnessAmir K Varkouhi, Ana Paula Teixeira Monteiro, James N Tsoporis, et al.
Pageof 6